Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Original Source
Read the full article at Cnbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.